Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 11634418 Amino acid compounds and methods of use

Patent 11634418 was granted and assigned to Pliant Therapeutics on April, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

0

Patent attributes

Patent Applicant

Pliant Therapeutics

Current Assignee

Pliant Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

0

Patent Number

Patent Inventor Names

David John Morgans, Jr.0

Timothy Hom0

Randall L. Halcomb0

Lan Jiang0

Jacob Cha0

Hui Li0

Gustave Bergnes0

Date of Patent

April 25, 2023

0

Patent Application Number

168947120

Date Filed

June 5, 2020

0

Patent Citations

US Patent 10131658 Anti-alphavbeta1 integrin compounds and methods

0

US Patent 10214522 Anti-alphavbeta1 integrin inhibitors and methods of use

0

US Patent 10604520 N-acyl amino acid compounds and methods of use

0

US Patent 10696672 Amino acid compounds and methods of use

0

US Patent 10793564 Amino acid compounds and methods of use

0

US Patent 11180494 Substituted amino acids as integrin inhibitors

0

Patent Citations Received

US Patent 11858931 Amino acid compounds with unbranched linkers and methods of use

0

US Patent 12018025 Integrin inhibitor and uses thereof

0

Patent Primary Examiner

0

CPC Code

0

0

0

0

0

0

0

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11634418 Amino acid compounds and methods of use

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.